Pleural Disease

The MRINZ has had a key role in setting up and coordinating the largest randomised controlled trial of the treatment of pneumothorax (collapsed lung). It challenges current dogma that the preferred treatment is an invasive approach based primarily on the insertion of a chest drain. The study, which has been undertaken over a five year period across 33 hospitals in Australia and New Zealand, has been completed, and the results will be available in 2018.

Comment: Through this study a strong network of trial centres in pleural disease has been built in Australia and New Zealand, and this will facilitate ongoing research.